Fludarabine plus cyclophosphamide prolongs disease-free survival in CLLBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7612.178-a (Published 26 July 2007) Cite this as: BMJ 2007;335:178
The combination of fludarabine and cyclophosphamide should be the standard treatment for chronic lymphocytic leukaemia (CLL), write British researchers. Patients treated with the combination had significantly longer progression-free survival than controls given fludarabine or chlorambucil in a trial comprising 777 mostly …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial